India's first mRNA COVID-19 vaccine to get EUA soon
SEC recommends India's first indigenously developed vaccine
SEC to discuss India's first indigenously developed vaccine again
New Delhi [India] June 15 (ANI): The first indigenously developed quadrivalent human papillomavirus (qHPV)...
SEC seek more data from SII over Covovax for 7-12 age group
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on...
Bharat Biotech asked to give more data on COVID vaccine Covaxin
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...
SEC's recommends Corbevax COVID-19 vaccines for kids aged 5-11
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...
DCGI to discuss to use COVID-19 vaccines for 5-12 age group
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller...
SEC recommends granting emergency use authorisation to Serum...
SEC recommends COVID-19 vaccine Corbevax for 12-18 year age...
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee...
Subject expert committee recommends Russia's Sputnik Light...
New Delhi [India], February 5 (ANI): The subject expert committee under India's drug regulator has recommended...
COVID-19: Nasal vaccine could be a game-changer if it...
SEC recommends regular market approval to Covaxin, Covishield...
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee...
Copyright © aninews.in | All Rights Reserved.